Tonix Pharmaceuticals Holding Corp. is scheduled to disclose its financial performance and operational achievements for the second quarter of 2026 on August 10 at 8:30 a.m. ET. The company, listed as TNXP on Nasdaq, will conduct a conference call and webcast to provide this update. Tonix, a biotechnology firm based in Berkeley Heights, New Jersey, which is fully integrated and operates at a commercial level, will share detailed information during this virtual event. This announcement signifies an important milestone in the company's ongoing progress.